88 related articles for article (PubMed ID: 16002550)
1. Short-term treatment with mycophenolic acid and tacrolimus is tolerogenic for INS-1 cell clone transplantation and the deleterious effects of the drugs are limited: in vivo and in vitro studies.
Asfari M; Berta S; Coffy S; Kergoat M; Charon C; Audet A
J Endocrinol; 2005 Jul; 186(1):213-20. PubMed ID: 16002550
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.
Paty BW; Harmon JS; Marsh CL; Robertson RP
Transplantation; 2002 Feb; 73(3):353-7. PubMed ID: 11884930
[TBL] [Abstract][Full Text] [Related]
3. GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone.
Prud'homme GJ; Glinka Y; Hasilo C; Paraskevas S; Li X; Wang Q
Transplantation; 2013 Oct; 96(7):616-23. PubMed ID: 23851932
[TBL] [Abstract][Full Text] [Related]
4. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
Hyder A; Laue C; Schrezenmeir J
Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells.
Gallo R; Natale M; Vendrame F; Boggi U; Filipponi F; Marchetti P; Laghi Pasini F; Dotta F
Acta Diabetol; 2012 Dec; 49 Suppl 1():S123-31. PubMed ID: 22249339
[TBL] [Abstract][Full Text] [Related]
7. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.
Johnson JD; Ao Z; Ao P; Li H; Dai LJ; He Z; Tee M; Potter KJ; Klimek AM; Meloche RM; Thompson DM; Verchere CB; Warnock GL
Cell Transplant; 2009; 18(8):833-45. PubMed ID: 19500470
[TBL] [Abstract][Full Text] [Related]
8. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
9. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.
Ferjani H; El Arem A; Bouraoui A; Achour A; Abid S; Bacha H; Boussema-Ayed I
J Physiol Biochem; 2016 Jun; 72(2):133-44. PubMed ID: 26746208
[TBL] [Abstract][Full Text] [Related]
11. Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study.
Nordheim E; Birkeland KI; Åsberg A; Hartmann A; Horneland R; Jenssen T
Eur J Endocrinol; 2018 Oct; 179(4):251-259. PubMed ID: 30299895
[TBL] [Abstract][Full Text] [Related]
12. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.
David-Neto E; Lemos FC; Fadel LM; Agena F; Sato MY; Coccuza C; Pereira LM; de Castro MC; Lando VS; Nahas WC; Ianhez LE
Transplantation; 2007 Jul; 84(1):50-5. PubMed ID: 17627237
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
14. Usage of Tacrolimus and Mycophenolic Acid During Conception, Pregnancy, and Lactation, and Its Implications for Therapeutic Drug Monitoring: A Systematic Critical Review.
Le HL; Francke MI; Andrews LM; de Winter BCM; van Gelder T; Hesselink DA
Ther Drug Monit; 2020 Aug; 42(4):518-531. PubMed ID: 32398419
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model.
Kriz J; Saudek F; Girman P; Novota P
Int J Tissue React; 2004; 26(3-4):75-83. PubMed ID: 15648439
[TBL] [Abstract][Full Text] [Related]
16. Antiaging Glycopeptide Protects Human Islets Against Tacrolimus-Related Injury and Facilitates Engraftment in Mice.
Gala-Lopez BL; Pepper AR; Pawlick RL; O'Gorman D; Kin T; Bruni A; Abualhassan N; Bral M; Bautista A; Manning Fox JE; Young LG; MacDonald PE; Shapiro AM
Diabetes; 2016 Feb; 65(2):451-62. PubMed ID: 26581595
[TBL] [Abstract][Full Text] [Related]
17. Oral immunosuppressive medication for growing pigs in transplantation studies.
Jensen-Waern M; Kruse R; Lundgren T
Lab Anim; 2012 Apr; 46(2):148-51. PubMed ID: 22398272
[TBL] [Abstract][Full Text] [Related]
18. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
19. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
20. Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression.
Lee D; Keymeulen B; Hilbrands R; Ling Z; Van de Velde U; Jacobs-Tulleneers-Thevissen D; Maleux G; Lapauw B; Crenier L; De Block C; Mathieu C; Pipeleers D; Gillard P
Transplantation; 2017 Sep; 101(9):2218-2227. PubMed ID: 27779572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
